Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Olivier Morel"'
Autor:
Rodolfo Citro, Jelena R. Ghadri, Christian Templin, Olivier Morel, Birke Schneider, Alexander R. Lyon, Elmir Omerovic
Publikováno v:
Journal of the American College of Cardiology. 77:902-921
Takotsubo syndrome (TTS) has been a recognized clinical entity for 31 years, since its first description in 1990. TTS is now routinely diagnosed in patients who present with acute chest pain, electrocardiographic changes, troponin elevation, unobstru
Autor:
Loïc Faucher, Laurence Jesel, Halim Marzak, T. Cardi, Mohamad Kanso, Lelia Grunebaum, Olivier Morel, Alexandre Schatz
Publikováno v:
European Heart Journal-Case Reports
European Heart Journal: Case Reports
European Heart Journal: Case Reports
Background Since the onset of the COVID-19 pandemic, several cardiovascular manifestations have been described. Among them, venous thromboembolism (VTE) seems to be one of the most frequent, particularly in intensive care unit patients. We report two
Autor:
Antje Reydel, Benjamin Marchandot, Marilou Peillex, Charline Jimenez, J. Heger, Lucie Lachmet-Thébaud, Adrien Carmona, Patrick Ohlmann, Chisato Sato, C. Dagrenat, Olivier Morel, Laurence Jesel, Kensuke Matsushita, Pierre Leddet, S. Greciano, Sébastien Hess, Fabien De Poli
Publikováno v:
ESC Heart Failure, Vol 8, Iss 1, Pp 259-269 (2021)
ESC Heart Failure
ESC Heart Failure
Aims Recent insights have emphasized the importance of myocardial and systemic inflammation in Takotsubo syndrome (TTS). In a large registry of unselected patients, we sought to evaluate whether residual high inflammatory response (RHIR) could impact
Autor:
Ngoc Thanh Kim, Benjamin Marchandot, Sébastien Hess, Dinh Phi Truong, Laurence Jesel, Anne Weiss, Patrick Ohlmann, Chisato Sato, Kensuke Matsushita, Olivier Morel
Publikováno v:
Journal of Thrombosis and Thrombolysis
Although a reduction in hospital admissions of acute coronary syndromes (ACS) patients has been observed globally during the coronavirus disease 2019 (COVID-19) pandemic, clinical features of those patients have not been fully investigated. The aim o
Autor:
Francois Schiele, Gilles Lemesle, Denis Angoulvant, Michel Krempf, Serge Kownator, Saida Cheggour, Loic Belle, Jean Ferrières, Christophe Bauters, Cyrille Bergerot, Farzin Beygui, Franck Boccara, Eric Bonnefoy, Eric Bruckert, Guillaume Cayla, Jean-Philippe Collet, Pierre Coste, Vincent Descotes-Genon, Gregory Ducrocq, Meyer Elbaz, Michel Farnier, Emile Ferrari, Dominique Guedj, Laszlo Levai, Jacques Mansourati, Nicolas Mansencal, Nicolas Meneveau, Christophe Meune, Olivier Morel, Patrick Ohlmann, Francois Paillard, Christophe Piot, Etienne Puymirat, Gilles Rioufol, François Roubille, Pierre Sabouret, Emmanuel Teiger
Publikováno v:
European Heart Journal: Acute Cardiovascular Care
European Heart Journal: Acute Cardiovascular Care, SAGE Publications, 2019, ⟨10.1177/2048872619844444⟩
European Heart Journal: Acute Cardiovascular Care, SAGE Publications, 2019, ⟨10.1177/2048872619844444⟩
In patients admitted for acute myocardial infarction, the communication and transition from specialists to primary care physicians is often delayed, and the information imparted to subsequent healthcare providers (HCPs) may be sub-optimal. A French g
Autor:
Benjamin Marchandot, Yves Hansmann, Kensuke Matsushita, Jecko Thachil, Chisato Sato, Anais Curtiaud, Laurence Jesel, Lelia Grunebaum, Laurent Sattler, Olivier Morel, Mickaël Ohana, Antonin Trimaille, Ian Leonard-Lorant, Adrien Carmona, Samira Fafi-Kremer
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 39, p 39 (2021)
Journal of Clinical Medicine
Volume 10
Issue 1
Journal of Clinical Medicine
Volume 10
Issue 1
Background and Objective: Host defence mechanisms to counter virus infection include the activation of the broncho-alveolar haemostasis. Fibrin degradation products secondary to extravascular fibrin breakdown could contribute to the marked increase i
Autor:
Wolfgang Koenig, Habib Gamra, Philippe L. L’Allier, Jean-Claude Tardif, François Roubille, Olivier Morel, Simon Kouz, Pascal Lim, David D. Waters, Colin Berry, Olivier F. Bertrand, Jean Grégoire, Michelle Samuel, Rafael Diaz, Nadia Bouabdallaoui, Fausto J. Pinto, Reda Ibrahim, Ghassan S. Kiwan, Marie-Claude Guertin, Andreas Orfanos, Aldo P. Maggioni, Lucie Blondeau, Marie-Pierre Dubé, Jose Lopez-Sendon
Publikováno v:
European Heart Journal
European Heart Journal, Oxford University Press (OUP), 2020, 41 (42), pp.4092-4099. ⟨10.1093/eurheartj/ehaa659⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2020, 41 (42), pp.4092-4099. ⟨10.1093/eurheartj/ehaa659⟩
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
European heart journal, vol 41, iss 42
European Heart Journal, 2020, 41 (42), pp.4092-4099. ⟨10.1093/eurheartj/ehaa659⟩
European Heart Journal, Oxford University Press (OUP), 2020, 41 (42), pp.4092-4099. ⟨10.1093/eurheartj/ehaa659⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2020, 41 (42), pp.4092-4099. ⟨10.1093/eurheartj/ehaa659⟩
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
European heart journal, vol 41, iss 42
European Heart Journal, 2020, 41 (42), pp.4092-4099. ⟨10.1093/eurheartj/ehaa659⟩
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons
Autor:
Benjamin Marchandot, Olivier Morel, Antonin Trimaille, Kensuke Matsushita, Laurence Jesel, Anais Curtiaud
Publikováno v:
Journal of Thrombosis and Thrombolysis
Journal of Thrombosis and Thrombolysis, 2020, 50 (4), pp.799-808. ⟨10.1007/s11239-020-02231-3⟩
Journal of Thrombosis and Thrombolysis, Springer Verlag (Germany), 2020, 50 (4), pp.799-808. ⟨10.1007/s11239-020-02231-3⟩
Journal of Thrombosis and Thrombolysis, 2020, 50 (4), pp.799-808. ⟨10.1007/s11239-020-02231-3⟩
Journal of Thrombosis and Thrombolysis, Springer Verlag (Germany), 2020, 50 (4), pp.799-808. ⟨10.1007/s11239-020-02231-3⟩
A common and potent consideration has recently entered the landscape of the novel coronavirus disease of 2019 (COVID-19): venous thromboembolism (VTE). COVID-19 has been associated to a distinctive related coagulopathy that shows unique characteristi
Publikováno v:
Archives of cardiovascular diseases
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2020, 113, pp.263-275. ⟨10.1016/j.acvd.2019.12.003⟩
Archives of cardiovascular diseases, 2020, 113, pp.263-275. ⟨10.1016/j.acvd.2019.12.003⟩
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2020, 113, pp.263-275. ⟨10.1016/j.acvd.2019.12.003⟩
Archives of cardiovascular diseases, 2020, 113, pp.263-275. ⟨10.1016/j.acvd.2019.12.003⟩
Transcatheter aortic valve replacement (TAVR) has emerged as the treatment of choice for patients with severe aortic stenosis deemed at high or intermediate risk for cardiac surgery. In light of the latest literature advances, TAVR will undoubtedly c
Autor:
B. Hoen, Amandine Pallardy, François Goehringer, Besma Mahida, Aurélie Bourdon, François Rouzet, Caroline Boursier, Zohra Lamiral, Nicolas Piriou, Olivier Morel, Véronique Roch, Elodie Chevalier, Pierre-Yves Marie, Xavier Duval, Christine Selton-Suty
Publikováno v:
Journal of Nuclear Cardiology
Journal of Nuclear Cardiology, Springer Verlag, 2021, 28 (6), pp.2533-2542. ⟨10.1007/s12350-020-02050-2⟩
Journal of Nuclear Cardiology, Springer Verlag, 2021, 28 (6), pp.2533-2542. ⟨10.1007/s12350-020-02050-2⟩
International audience; Purpose: This study aimed at determining the diagnostic implications of indirect signs of infection at FDG-PET-i.e., hypermetabolisms of the spleen and/or bone marrow (HSBM)-when documented in patients with known or suspected